ANTG is a proudly Australian, independently owned medicinal cannabis focused company.
We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive high quality cannabinoid-based medical treatments that can meet individual patient needs.
“Our pioneering approach is underpinned by deep expertise and a commitment to reduce suffering and improve people’s lives through the research, development and clinical application of cannabinoid-based medical treatments”
MATT CANTELO, ANTG CHIEF EXECUTIVE OFFICER.
Chris Wright, Brisbane local who was diagnosed with Tourette’s syndrome at the age of 12 is one of the first patients recruited for the trial run by Brisbane’s Wesley Medical Research. The trial aims to assess the effects of medicinal cannabis on symptoms such as uncontrollable physical and/or verbal ticks.
Thanks to new streamlined processes, Queensland specialist doctors soon will be able to prescribe medicinal cannabis directly to their patients, meaning the medicine will be treated just like any other prescription drug in Queensland.
A story of six year old Cooper who has been diagnosed with Epilepsy two years ago. After trying a range of traditional medications over the years with very little success, Cooper’s parents decided to start on medicinal product to help him with seizures that have eventually stopped.
Matt Cantelo recently sat down with leading business publication, My Business to discuss the future of the Australian medicinal cannabis industry, ANTG’s plans for growth, the role of the industry to facilitate greater research and ANTG’s exciting partnership to export Australian grown cannabis to the German market.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >
